Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2FAT

An anti-urokinase plasminogen activator receptor (UPAR) antibody: Crystal structure and binding epitope

Summary for 2FAT
Entry DOI10.2210/pdb2fat/pdb
DescriptorFAB ATN-615, light chain, FAB ATN-615, heavy chain (3 entities in total)
Functional Keywordsanti-upar antibody, atn-615, fab, immune system
Biological sourceMus musculus (mouse)
More
Total number of polymer chains2
Total formula weight46311.43
Authors
Li, Y.,Parry, G.,Shi, X.,Chen, L.,Callahan, J.A.,Mazar, A.P.,Huang, M. (deposition date: 2005-12-07, release date: 2006-11-14, Last modification date: 2024-10-16)
Primary citationLi, Y.,Parry, G.,Chen, L.,Callahan, J.A.,Shaw, D.E.,Meehan, E.J.,Mazar, A.P.,Huang, M.
An anti-urokinase plasminogen activator receptor (uPAR) antibody: crystal structure and binding epitope
J.Mol.Biol., 365:1117-1129, 2007
Cited by
PubMed Abstract: Human urokinase-type plasminogen activator receptor (uPAR/CD87) is expressed at the invasive interface of the tumor-stromal microenvironment in many human cancers and interacts with a wide array of extracellular molecules. An anti-uPAR antibody (ATN615) was prepared using hybridoma technology. This antibody binds to uPAR in vitro with high affinity (K(d) approximately 1 nM) and does not interfere with uPA binding to uPAR. Here we report the crystal structure of the Fab fragment of ATN615 at 1.77 A and the analysis of ATN615-suPAR-ATF structure that was previously determined, emphasizing the ATN615-suPAR interaction. The complementarity determining regions (CDRs) of ATN615 consist of a high percentage of aromatic residues, and form a relatively flat and undulating surface. The ATN615 Fab fragment recognizes domain 3 of suPAR. The antibody-antigen recognition involves 11 suPAR residues and 12 Fab residues from five CDRs. Structural data suggest that Pro188, Asn190, Gly191, and Arg192 residues of uPAR are the key residues for the antibody recognition, while Pro189 and Arg192 render specificity of ATN615 for human uPAR. Interestingly, this antibody-antigen interface has a small contact area, mainly polar interaction with little hydrophobic character, yet has high binding strength. Furthermore, several solvent molecules (assigned as polyethylene glycols) were clearly visible in the binding interface between antibody and antigen, suggesting that solvent molecules may be important for the maximal binding between suPAR and ATN615 Fab. ATN615 undergoes small but noticeable changes in its CDR region upon antigen binding.
PubMed: 17101149
DOI: 10.1016/j.jmb.2006.10.059
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.77 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon